These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32205094)

  • 41. The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice.
    Li X; Liu R; Yang J; Sun L; Zhang L; Jiang Z; Puri P; Gurley EC; Lai G; Tang Y; Huang Z; Pandak WM; Hylemon PB; Zhou H
    Hepatology; 2017 Sep; 66(3):869-884. PubMed ID: 28271527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice.
    Zhou M; Learned RM; Rossi SJ; DePaoli AM; Tian H; Ling L
    Hepatology; 2016 Mar; 63(3):914-29. PubMed ID: 26418580
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective effect of herbal medicine Huangqi decoction against chronic cholestatic liver injury by inhibiting bile acid-stimulated inflammation in DDC-induced mice.
    Li WK; Wang GF; Wang TM; Li YY; Li YF; Lu XY; Wang YH; Zhang H; Liu P; Wu JS; Ma YM
    Phytomedicine; 2019 Sep; 62():152948. PubMed ID: 31129431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting FXR in Cholestasis.
    Keitel V; Dröge C; Häussinger D
    Handb Exp Pharmacol; 2019; 256():299-324. PubMed ID: 31201556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benefit of farnesoid X receptor inhibition in obstructive cholestasis.
    Stedman C; Liddle C; Coulter S; Sonoda J; Alvarez JG; Evans RM; Downes M
    Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11323-8. PubMed ID: 16844773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The thyroid hormone receptor-beta agonist GC-1 induces cell proliferation in rat liver and pancreas.
    Columbano A; Pibiri M; Deidda M; Cossu C; Scanlan TS; Chiellini G; Muntoni S; Ledda-Columbano GM
    Endocrinology; 2006 Jul; 147(7):3211-8. PubMed ID: 16574785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thyroid Hormone Receptor-β Agonist GC-1 Inhibits Met-β-Catenin-Driven Hepatocellular Cancer.
    Puliga E; Min Q; Tao J; Zhang R; Pradhan-Sundd T; Poddar M; Singh S; Columbano A; Yu J; Monga SP
    Am J Pathol; 2017 Nov; 187(11):2473-2485. PubMed ID: 28807594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of A(1) adenosine receptor attenuates alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice.
    Yang P; Chen P; Wang T; Zhan Y; Zhou M; Xia L; Cheng R; Guo Y; Zhu L; Zhang J
    Toxicol Sci; 2013 Jan; 131(1):128-38. PubMed ID: 22956627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adenovirus-mediated human aquaporin-1 expression in hepatocytes improves lipopolysaccharide-induced cholestasis.
    Marrone J; Danielli M; Gaspari CI; Marinelli RA
    IUBMB Life; 2017 Dec; 69(12):978-984. PubMed ID: 29087027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formononetin ameliorates cholestasis by regulating hepatic SIRT1 and PPARα.
    Yang S; Wei L; Xia R; Liu L; Chen Y; Zhang W; Li Q; Feng K; Yu M; Zhang W; Qu J; Xu S; Mao J; Fan G; Ma C
    Biochem Biophys Res Commun; 2019 May; 512(4):770-778. PubMed ID: 30928103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis.
    Trauner M; Wagner M; Fickert P; Zollner G
    J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S111-24. PubMed ID: 15758646
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sobetirome: the past, present and questions about the future.
    Lammel Lindemann J; Webb P
    Expert Opin Ther Targets; 2016; 20(2):145-9. PubMed ID: 26565124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Basal efflux of bile acids contributes to drug-induced bile acid-dependent hepatocyte toxicity in rat sandwich-cultured hepatocytes.
    Susukida T; Sekine S; Ogimura E; Aoki S; Oizumi K; Horie T; Ito K
    Toxicol In Vitro; 2015 Oct; 29(7):1454-63. PubMed ID: 26055650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.
    Kok T; Bloks VW; Wolters H; Havinga R; Jansen PL; Staels B; Kuipers F
    Biochem J; 2003 Feb; 369(Pt 3):539-47. PubMed ID: 12381268
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The pathophysiology of cholestasis with special reference to primary biliary cirrhosis.
    Jansen PL
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):571-83. PubMed ID: 10976015
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
    Fickert P; Fuchsbichler A; Wagner M; Zollner G; Kaser A; Tilg H; Krause R; Lammert F; Langner C; Zatloukal K; Marschall HU; Denk H; Trauner M
    Gastroenterology; 2004 Jul; 127(1):261-74. PubMed ID: 15236191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severe cholestasis induced by cholic acid feeding in knockout mice of sister of P-glycoprotein.
    Wang R; Lam P; Liu L; Forrest D; Yousef IM; Mignault D; Phillips MJ; Ling V
    Hepatology; 2003 Dec; 38(6):1489-99. PubMed ID: 14647060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH).
    Luong XG; Stevens SK; Jekle A; Lin TI; Gupta K; Misner D; Chanda S; Mukherjee S; Williams C; Stoycheva A; Blatt LM; Beigelman LN; Symons JA; Raboisson P; McGowan D; Vandyck K; Deval J
    PLoS One; 2020; 15(12):e0240338. PubMed ID: 33306682
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
    Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
    Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sphingosine 1-phosphate receptor-1 specific agonist SEW2871 ameliorates ANIT-induced dysregulation of bile acid homeostasis in mice plasma and liver.
    Yang T; Wang X; Yuan Z; Miao Y; Wu Z; Chai Y; Yu Q; Wang H; Sun L; Huang X; Zhang L; Jiang Z
    Toxicol Lett; 2020 Oct; 331():242-253. PubMed ID: 32579994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.